Background illustration for clinical trials search

Paid Clinical Trials Plano

Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Dallas TX, Frisco TX, Norman OK, Austin TX,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

for
Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder
Location: Plano TX, Coppell TX, Fort Worth TX, Norman OK,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06229210

Phase 3, Recruiting

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

for
Attention-Deficit/Hyperactivity Disorder
Location: Plano TX, The Woodlands TX, Little Rock AR,
Sponsor: Supernus Pharmaceuticals, Inc.

Sex: All

Age: 4 - 5

Code: NCT04781140

Recruiting

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Migraine
Location: Plano TX, Dallas TX, Waxahachie TX, Lampasas TX,
Sponsor: TriGemX Bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07645924

Phase 3, Recruiting

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Acute Migraine
Location: Plano TX, Dallas TX, Waxahachie TX, Lampasas TX,
Sponsor: TriGemX Bio, Inc.

Sex: All

Age: 18+

Code: NCT07674654

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

for
Irritability Associated With Autism Spectrum Disorder
Location: Plano TX, Richmond TX, Houston TX, Beaumont TX,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06690398

Phase 3, Recruiting

Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor

for
Upper Limb Essential Tremor
Location: Frisco TX, Dallas TX, Houston TX, Memphis TN,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07673107

Phase 2, Recruiting

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for
Major Depressive Disorder
Location: Dallas TX, Houston TX, Little Rock AR, Maitland FL,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT06786624

Phase 3, Recruiting

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

for
Narcolepsy Type 1, Narcolepsy Type 2
Location: Dallas TX, Frisco TX, Austin TX, Houston TX,
Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 70

Code: NCT07598708

Phase 2, Phase 3, Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

for
Narcolepsy Type 1
Location: Dallas TX, McKinney TX, Frisco TX, Sugar Land TX,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT07540897

Phase 3, Recruiting

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Dallas TX, Austin TX, Sugar Land TX, San Antonio TX,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06767683

Phase 2, Phase 3, Recruiting

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for
Peripheral Artery Disease (PAD)
Location: Plano TX, DeSoto TX, Oklahoma City OK, Shreveport LA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318610

Phase 3, Recruiting

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

for
Metabolic Dysfunction Associated Steatohepatitis (MASH),
Location: Plano TX, Dallas TX, Carrollton TX, Garden City TX,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06632444

Phase 3, Recruiting

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

for
Macular Telangiectasia Type 2 (MacTel)
Location: Dallas TX, Houston TX, Lakewood CO, Atlanta GA,
Sponsor: Neurotech Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06971939

Recruiting

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Plano TX, Oklahoma City OK, Austin TX, Atlanta GA,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 0+

Code: NCT06480383

Phase 2, Recruiting

Home With TablO outcoMEs (HOME) Registry

for
End Stage Renal Disease
Location: Plano TX, Lincoln NE, Helena MT, New York NY,
Sponsor: Outset Medical

Sex: All

Age: 15+

Code: NCT04526301

Recruiting

Complex Adult Deformity Surgery (CADS)

for
Adult Spinal Deformity, Scoliosis, Kyphosis, Sagittal Imbalance
Location: Dallas TX, Shreveport LA, Houston TX, Kansas City KS,
Sponsor: International Spine Study Group Foundation

Sex: All

Age: 18+

Code: NCT04194138

Recruiting

Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity: A Multi-Center Study 2.0

for
Cervical Deformity
Location: Dallas TX, Kansas City KS, Denver CO, Louisville KY,
Sponsor: International Spine Study Group Foundation

Sex: All

Age: 18+

Code: NCT04194996

Recruiting

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

for
Narcolepsy, Idiopathic Hypersomnia
Location: Dallas TX, Austin TX, Sugar Land TX, Daphne AL,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07625280

Phase 3, Recruiting

A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Dallas TX, DeSoto TX, Oklahoma City OK,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18+

Code: NCT07759128

Phase 3, Recruiting